Home > Result Summaries: Compounds > abacavir/lamivudine/zidovudine > Result Summary for NZTA4006

Result Summary for NZTA4006

Result Summary

Protocol ID:	NZTA4006
Clinical Study ID:	NZTA4006
Official Title:	A Phase IIIB, Open-Label, Randomized Study of the Effect of an Education Intervention on Virologic Outcomes, Adherence, Immunologic Outcome, and Health Outcomes in HIV-Infected Subjects from Under-Represented Populations Treated with Triple Nucleoside Therapy (COMBIVIR, Lamivudine 150mg/Zidovudi ...
Phase:	Phase 3
Study Indications or Diseases:	Infection, Human Immunodeficiency Virus
Generic Name:	abacavir/lamivudine/zidovudine
Trade/Product Name:	trizivir;trizivir
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Rawlings MK, Thompson MA, Farthing CF, Brown LS, Racine J et al. Impact of an Education Program on Efficacy and Adherence with a Twice-daily Lamivudine/Zidovudine/Abacavir Regimen in Underrepresented HIV-infected Patients. J Acquir Immune Defic Syndr 2003; 34 (2): 174-83.